Molecular Partners Ag (MOLN) Operating Margin (QoQ) (2020 - 2024)
Molecular Partners Ag (MOLN) Operating Margin (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 214.23 Bn |
| Sep 30, 2024 | -111.22 Bn |
| Jun 30, 2024 | -103.00 Bn |
| Mar 31, 2024 | 28,919.00 |
| Dec 31, 2023 | -33,751.00 |
| Sep 30, 2023 | 329,637.00 |
| Jun 30, 2023 | -333,254.00 |
| Mar 31, 2023 | -49,463.00 |
| Dec 31, 2022 | 62,143.00 |
| Sep 30, 2022 | -56,797.00 |
| Jun 30, 2022 | -14,181.00 |
| Mar 31, 2022 | 73,851.00 |
| Dec 31, 2021 | -28,687.00 |
| Sep 30, 2021 | 153,328.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | -127,148.00 |
| Dec 31, 2020 | -62,514.00 |